AKTX vs PVH · $17.2M cap vs P/E 24, rev $8.95B
Akari Therapeutics PLC (AKTX) versus PVH Corp (PVH) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
PVH Corp (PVH) is a apparel manufacturing company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported PVH revenue for 2026-02-01 was $8.95B. Net income was $25.3M. Revenue was up 3.4% from 2025-02-02 to 2026-02-01. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
AKTX currently screens at market cap $17.2M. PVH currently screens at market cap $3.60B and trailing P/E 23.7.
Not investment advice. Open the AKTX and PVH stock pages for the full models.
Not investment advice.